DE2013039A1 - Arzneimitteltablette zur oralen Verabreichung - Google Patents

Arzneimitteltablette zur oralen Verabreichung

Info

Publication number
DE2013039A1
DE2013039A1 DE19702013039 DE2013039A DE2013039A1 DE 2013039 A1 DE2013039 A1 DE 2013039A1 DE 19702013039 DE19702013039 DE 19702013039 DE 2013039 A DE2013039 A DE 2013039A DE 2013039 A1 DE2013039 A1 DE 2013039A1
Authority
DE
Germany
Prior art keywords
tablet according
compound
water
citrate
tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19702013039
Other languages
German (de)
English (en)
Inventor
Joseph Stanley Kent Dwight, (Großbritannien). P A6lk 13-07
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Original Assignee
Pfizer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp filed Critical Pfizer Corp
Publication of DE2013039A1 publication Critical patent/DE2013039A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
DE19702013039 1969-03-20 1970-03-19 Arzneimitteltablette zur oralen Verabreichung Pending DE2013039A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB04670/69A GB1291281A (en) 1969-03-20 1969-03-20 Improvements in pharmaceutical compositions

Publications (1)

Publication Number Publication Date
DE2013039A1 true DE2013039A1 (de) 1970-09-24

Family

ID=10045462

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19702013039 Pending DE2013039A1 (de) 1969-03-20 1970-03-19 Arzneimitteltablette zur oralen Verabreichung

Country Status (10)

Country Link
BE (1) BE747656A (da)
DE (1) DE2013039A1 (da)
DK (1) DK128674B (da)
ES (1) ES377725A1 (da)
FI (1) FI51653C (da)
FR (1) FR2035118B1 (da)
GB (1) GB1291281A (da)
IL (1) IL34089A (da)
NL (1) NL143419B (da)
SE (1) SE379284B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2083622B1 (da) * 1970-03-27 1975-08-22 Sankyo Co
US3969524A (en) * 1974-08-13 1976-07-13 Hoffmann-La Roche Inc. Stable amoxicillin dosage form
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
EP0012495B1 (en) * 1978-12-08 1983-06-22 Beecham Group Plc Pharmaceutical composition comprising a water soluble salt of amoxycillin and polyvinylpyrrolidone, and a vial containing a unit dose of said composition
CA2061520C (en) * 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2438106A (en) * 1944-06-09 1948-03-23 Wyeth Corp Peroral penicillin compositions
US2864744A (en) * 1955-09-02 1958-12-16 American Home Prod Penicillin in solid dosage unit form
US3131123A (en) * 1959-03-13 1964-04-28 Lab Francais De Therapeutique Enteric tablets and manufacture thereof
GB1276839A (en) * 1968-08-02 1972-06-07 Sandoz Products Ltd Antibiotic compositions

Also Published As

Publication number Publication date
FI51653B (da) 1976-11-30
GB1291281A (en) 1972-10-04
NL143419B (nl) 1974-10-15
FR2035118B1 (da) 1974-08-30
IL34089A (en) 1974-05-16
DK128674B (da) 1974-06-17
IL34089A0 (en) 1970-05-21
FI51653C (fi) 1977-03-10
NL7004004A (da) 1970-09-22
SE379284B (da) 1975-10-06
BE747656A (fr) 1970-09-21
FR2035118A1 (da) 1970-12-18
ES377725A1 (es) 1972-10-16

Similar Documents

Publication Publication Date Title
DE69109021T2 (de) Augentropfenarzneimittel.
DE69419019T2 (de) Gelatinekaiseln die eine hochdosierte acetaminophenlösung enthalten
DE69319480T2 (de) Badepräparat
EP0178436A1 (de) Ibuprofen enthaltende Weichgelatinekapseln und Verfahren zu ihrer Herstellung
AT393221B (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
DE60107272T2 (de) Eisenverbindungen
DE69108022T3 (de) Arzneimittel.
DE69427981T2 (de) Verkapselter arzneistoff
DE3314150A1 (de) Zahnzement
DE2013039A1 (de) Arzneimitteltablette zur oralen Verabreichung
DE3408085A1 (de) Pharmazeutische praeparate mit gleichbleibenden elutionseigenschaften
DE2205272A1 (da)
EP0641200B1 (de) 2-arylpropionsäure-zubereitungen und verfahren zu ihrer herstellung
DE2126533A1 (de) Verfahren zur Herstellung pharma zeutischer Zubereitungen
DE2013040A1 (de) Arzneimitteltablette zur oralen Verabreichung
DE19912436A1 (de) Ibuprofen-Lösung
DE2416216A1 (de) Pharmazeutische zusammensetzung, verfahren zu deren herstellung und verwendung eines vehiculums dafuer
DE3208505C2 (da)
US2715622A (en) Anthelmintic dye salts
DE2950832C2 (de) Spritzfertige injizierbare wäßrige Lösungen der Alkalisalze von Canrenoinsäure und Furosemid
DE1086012B (de) Verfahren zur Herstellung von protrahiert wirkenden Vitamin-B-Praeparaten
DE68902755T2 (de) Antineoplastische formulierungen.
DE4109508C1 (en) 2-phenyl-1,2-benz:iso:selenazol-3(2H)-1-one - used for treating diabetes and diseases caused by inflammation of islet cells
DE2102889C3 (de) Verwendung von SuIf adimidin und Pyrimethamin
DE2538678A1 (de) Injizierbare loesungen